{"id":"W4318539491","doi":"10.1093/ecco-jcc/jjac190.0081","title":"DOP41 Achievement of corticosteroid-free clinical endpoints in subjects with ulcerative colitis: an analysis of the phase 3 ELEVATE UC 52 trial","year":2023,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada); University of British Columbia","funders":"","keywords":"Medicine; Ulcerative colitis; Internal medicine; Gastroenterology; Prednisone; Placebo; Budesonide; Population; Corticosteroid; Clinical endpoint; Concomitant; Randomized controlled trial; Randomization; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004172455,0.001004283,0.002420647,0.0003075184,0.0003144649,0.001146277,0.0004862758,0.00121412,0.004432288],"category_scores_gemma":[0.002892729,0.0002942645,0.00242243,0.0005315938,0.0004853413,0.0006510498,0.0005448104,0.002031504,0.0006113854],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004192816,"about_ca_system_score_gemma":0.0007542773,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004340558,"about_ca_topic_score_gemma":0.001368934,"domain_scores_codex":[0.9981616,0.001349719,0.00008900704,0.0001549141,0.0001188453,0.000125889],"domain_scores_gemma":[0.9982338,0.0006589033,0.0004813207,0.0001611082,0.0001318463,0.0003329671],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9614078,0.001763712,0.003465628,0.001705673,0.004660974,0.0001026801,0.00005390251,0.0005551665,0.003329861,0.0001484894,0.002876112,0.01993002],"study_design_scores_gemma":[0.8625425,0.1022947,0.02309134,0.0002255887,0.005457862,0.0001916229,0.00008187762,0.0009133306,0.0005971783,0.0004612836,0.004082189,0.00006058947],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9551048,0.02815989,0.0006465465,0.001252331,0.0003675229,0.002287128,0.006027502,0.0001241663,0.006030058],"genre_scores_gemma":[0.9827185,0.004911873,0.0008148968,0.001589949,0.0003864668,0.002035938,0.005462948,0.00003618592,0.002043322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004432288,"threshold_uncertainty_score":0.02206635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0315712233884626,"score_gpt":0.3467533657058893,"score_spread":0.3151821423174267,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}